Current status of yttrium-90 microspheres radioembolization in primary and metastatic liver cancer
Publication date
2023-11
Authors
Anbari, Yasaman
Veerman, Floortje E.
Keane, Grace
Braat, Arthur J.A.T.
Smits, Maarten Leonard Johannes
Bruijnen, Rutger C.G.
Tan, Wenle
Li, Ye
Duan, Feng
G. E. H. Lam, Marnix
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
cc_by_nc_nd
Abstract
Liver malignancy, including primary liver cancer and metastatic liver cancer has become one of the most common causes of cancer-related death worldwide due to the high malignant degree and limited systematic treatment strategy. Radioembolization with yttrium-90 (90Y)-loaded microspheres is a relatively novel technology that has made significant progress in the local treatment of liver malignancy. The different steps in the extensive work-up of radioembolization for patients with an indication for treatment with 90Y microspheres, from patient selection to follow up, both technically and clinically, are discussed in this paper. It describes the application and development of 90Y microspheres in the treatment of liver cancer.
Keywords
Metastatic liver cancer, Primary liver cancer, Selective internal radiation therapy, Trans-arterial radioembolization, Yttrium-90 microspheres, General Medicine
Citation
Anbari, Y, Veerman, F E, Keane, G, Braat, A J A T, Smits, M L J, Bruijnen, R C G, Tan, W, Li, Y, Duan, F & Lam, M G E H 2023, 'Current status of yttrium-90 microspheres radioembolization in primary and metastatic liver cancer', Journal of Interventional Medicine, vol. 6, no. 4, pp. 153-159. https://doi.org/10.1016/j.jimed.2023.09.001